glp 1 effect on kidneys GLP-1 Receptor Agonists and Kidney Protection Glucagon-like Peptide-1 Receptor Agonists and
Description
The most important thing to know about these medications is that losing weight with either medication takes time
Study participants were an average of 50 years old, with 66% percent identifying as female
No pharmacotherapy is approved for the treatment of NAFLD and, currently, the cornerstone treatment is lifestyle modifications focusing on bodyweight loss, notoriously difficult to obtain and even more difficult to maintain
Framing the conversation around your health and well-being can help your doctor see the bigger picture
For more details on expectations, see How Long Does It Take for GLP-1 to Work
